• Corvus Pharmaceuticals, Inc. (CRVS) Reaches $7.95 Low on Feb, 11; SANTACRUZ SILVER …

    The stock of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) reached all time low today, Feb, 11 and still has $7.63 target or 4.00% below today’s $7.95 share price. This indicates more downside for the $167.28 million company. This technical setup was reported by Barchart.com. If the $7.63 PT is …

    Read More